Cargando…
Increased induction of de novo serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2
Different immune-mediated diseases have been described after SARS-CoV-2 vaccination, with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) being one of the possible side effects. In this study, a total of 35 patients presented ANCA for the first time during 2021, with the num...
Autores principales: | Irure-Ventura, Juan, Belmar-Vega, Lara, Fernández-Fresnedo, Gema, González-López, Elena, Castro-Hernández, Carolina, Rodrigo-Calabia, Emilio, Heras-Vicario, Milagros, Ruiz San Millán, Juan Carlos, López-Hoyos, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344695/ https://www.ncbi.nlm.nih.gov/pubmed/35937087 http://dx.doi.org/10.1016/j.isci.2022.104847 |
Ejemplares similares
-
Non-Criteria Antiphospholipid Antibodies: Risk Factors for Endothelial Dysfunction in Women with Pre-Eclampsia
por: Belmar Vega, Lara, et al.
Publicado: (2020) -
ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020) -
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019) -
De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020) -
The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)